Société

Spineart est une société privée qui a pour objectif la simplification de l’acte chirurgical, en concevant, développant et promouvant des dispositifs médicaux sûrs et efficaces pour les chirurgiens de la colonne vertébrale, les équipes de salle d’opération et les patients.

Spineart est pionnier dans les domaines de la chirurgie mini-invasive, de la préservation de la mobilité, de la fusion, des biologiques et du traitement des fractures, ayant introduit des technologies optimales.

Spineart commercialise une gamme complète d’implants conditionnés stériles avec un code-barre, des ancillaires d’instruments compacts, renforçant ainsi la traçabilité, la sécurité et la rentabilité pour tous nos partenaires.

Leadership

Notre comité exécutif, composé de 7 leaders de l’industrie des dispositifs médicaux, travaille main dans la main avec le Conseil d’Administration afin de développer les technologies qui changeront le futur de l’industrie.

«En équipe, nous guidons Spineart afin d’accomplir notre mission d’améliorer la santé des patients en simplifiant l’acte chirurgical.»,
Jerome Trividic, CEO

Comité de Direction

Conseil d’Administration

Upcoming events

All events

Latest News

16 Nov 2023

GROUNDBREAKING CEREMONY OF OUR NEW FACTORY!

We are building a new factory and broke ground on October 26^th, 2023.

Built on a 7,000 sqm (70,000 sqft) greenfield development lot, the new Spineart factory is our third production site and our largest so far with more than 4,200 sqm (42,000 sqft) and will eventually regroup all our manufacturing and logistics activities. It will be equipped with state-of-the-art additive manufacturing, CNC machines and a new clean room. This new site will support Spineart continued double-digit growth through a significant manufacturing footprint expansion and the integration of the latest manufacturing innovations as well as sustainability standards.

The new factory is located close to our global headquarters in Geneva, Switzerland, in a region renowned for being a center of excellence for precision manufacturing.

The official opening of the new Spineart factory is scheduled early 2025.

17 Oct 2023

SPINEART HAS REACHED AND SURPASSED THE €100M OF REVENUE.

For the first time in its history, Spineart has reached and surpassed €100m of trailing 12-month revenue.

As the success and expansion of the Ti-LIFE ranges continues, we are rolling out the posterior fixation PERLA® platform and actively invest and develop multiple enabling technologies for spine surgeries, as exemplified by its co-development agreement with eCential robotics.

We are steadily gaining market share in Europe where the MDR certification of our full portfolio is well ahead of our peers and in the US through the addition of state-of-the-art systems to our portfolio. Our 2 US IDE trials for the BAGUERA® C cervical disc prothesis are enrolling at full speed and we are aiming for enrollment completion in the coming months. Meanwhile the 10-year safety and efficacy data for BAGUERA® C collected from Europe have been published in the prestigious European Spine Journal.

Spineart is committed to transform spine surgery for patients, surgeons and hospitals as we aim to create safe solutions and ultimately advance healthcare worldwide.

27 Sep 2023

FIRST WOMEN SPINE NETWORK!

For the first time in its history, Spineart has organized an exclusive event for women in the Spine industry in Luzern, Switzerland last week.

The goal of this program was to offer women spine surgeons a dedicated platform to advance the dialogue on important spine topics, make lasting connections and inspire each other.

Considering the quality of the exchanges between the 22 participants who addressed scientific subjects but also discussed how to strengthen the science ecosystem together, we are delighted to share that the mission was accomplished!

We would like to thank all our special guests Susanne Siegenthaler, Military pilot in the Swiss Air Force, Dr. Med. Nermine Habib, Founder and President of Swiss Female Orthopaedics, Dr. Adéla Wyncoll, Co-Founder and managing partner of Women’s Leadership Academy and Dr. Med. Dominique Kuhlen, Chief Clinical Officer of the Hirslanden Group. A special thanks also goes to our speakers Dr. Caroline Hirsch, Dr. Sara Burguet, Dr. Lima Sprenger, Dr. Sonja Häckel and Dr. Raluca Reitmeier and to all the participants.

We are absolutely certain that this event will be the first of a long list and we can’t wait for the next editions!

All news

Great Place to Work

Notre Philosophie : Quality, Innovation, Simplicity

Notre Vision: Devenir un acteur clé unique et global dans le domaine du rachis.

Notre Mission: Améliorer la santé des patients en simplifiant l’acte chirurgical.

Nos Valeurs :

Respect
Intégrité
Orienté Solution

Notre politique ressource humaine: Attirer, développer et retenir les talents.

Une entreprise, une culture.

Rejoignez-nous!

Job Opportunities

Posted 2 jours ago

Process Validation Engineer

Clinical Project Manager

Investors

Nous avons un profond engagement pour servir au mieux les intérêts de nos investisseurs. Veuillez trouver les informations clés et les rapports financiers qui vous permettront de mettre en perspective les performances financières de Spineart.

All news